Capital Flow Monitor · Sponsors · CIK 1823161
Prometheus Therapeutics Inc.
10370 USA TODAY WAY, MIRAMAR, FL, 33025 · (786) 565-3321
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$6.5M
Sold
$2.7M
% sold
42.2%
Investors
13
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-15 | D/A ·current | 506(b) | $6.5M | $2.7M | 42.2% | 13 | EDGAR ↗ |
| 2025-11-12 | D | 506(b) | $5.0M | $130K | 2.6% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Ajay Wakhloo — Executive Officer / Director, MIRAMAR, FL
2 other raises
- NeuroFine Corp. $1.0M of $1.0M · 100.0%
- Deinde Medical Corp. $185K of $2.0M · 9.3%
- Alexander Hastings — Director, MIRAMAR, FL
- Baruch Lieber — Executive Officer / Director, MIRAMAR, FL
-
John McEleney — Director, MIRAMAR, FL
3 other raises
- Verve, Inc. $12.8M of $16.4M · 77.7%
- NeuroFine Corp. $1.0M of $1.0M · 100.0%
- Deinde Medical Corp. $185K of $2.0M · 9.3%
-
Bernie Navarro — Executive Officer, MIRAMAR, FL
2 other raises
- NeuroFine Corp. $1.0M of $1.0M · 100.0%
- Deinde Medical Corp. $185K of $2.0M · 9.3%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.